Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter, Phase III, Randomized, Placebo-controlled Trial Evaluating the Efficacy and Safety of Bevacizumab in Combination With Chemotherapy Regimens in Subjects With Previously Untreated Metastatic Breast Cancer

NCT00262067 is registered in ClinicalTrials.gov with Genentech, Inc. as lead sponsor.

NCT NCT00262067
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00262067 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter, Phase III, Randomized, Placebo-controlled Trial Evaluating the Efficacy and Safety of Bevacizumab in Combination With Chemotherapy Regimens in Subjects With Previously Untreated Metastatic Breast Cancer
Lead sponsor
Genentech, Inc.
Phase
Phase 3
Overall status
Unknown status
Start date
December 31, 2005
Completion date
December 31, 2013
Enrollment
1,237 (actual)
Sites
92

Conditions

As the registry lists them; a condition with its own page is linked.

metastatic breast cancer